| 发明名称 |
CCR3 MODULATION IN THE TREATMENT OF AGING-ASSOCIATED IMPAIRMENTS, AND COMPOSITIONS FOR PRACTICING THE SAME |
| 摘要 |
Methods of treating an adult mammal for an aging-associated impairment are provided. Aspects of the methods include modulating CCR3, e.g., by modulating eotaxin-1/CCR3 interaction, in the mammal in a manner sufficient to treat the mammal for the aging-associated impairment. A variety of aging-associated impairments may be treated by practice of the methods, which impairments include cognitive impairments. |
| 申请公布号 |
US2016208011(A1) |
申请公布日期 |
2016.07.21 |
| 申请号 |
US201614991813 |
申请日期 |
2016.01.08 |
| 申请人 |
The Board of Trustees of the Leland Stanford Junior University ;The United States Government as represented by the Department of Veterans Affairs |
发明人 |
Wyss-Coray Anton;Rando Thomas A.;Britschgi Markus;Rufibach Kaspar;Villeda Saul Abraham |
| 分类号 |
C07K16/28;C12N15/113;A61K38/45;C07K16/24;A61K38/19 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating an adult mammal for an aging-associated impairment, the method comprising:
modulating CCR3 in the mammal in a manner sufficient to treat the adult mammal for the aging-associated impairment. |
| 地址 |
Stanford CA US |
